Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2020 | 08-2019 | 08-2018 | 08-2017 | 08-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,294 | 1,285 | 1,727 | 2,533 | 93 |
| Marketable Securities | 19 | 64 | 10 | N/A | N/A |
| Receivables | 314 | 273 | 266 | 45 | 131 |
| Inventories | 117 | 127 | 87 | 67 | 135 |
| TOTAL | $1,926 | $1,819 | $2,284 | $2,795 | $510 |
| Non-Current Assets | |||||
| PPE Net | 610 | 591 | 1 | 2 | 2 |
| Intangibles | 292 | 265 | 147 | 63 | 54 |
| TOTAL | $902 | $856 | $148 | $65 | $56 |
| Total Assets | $2,828 | $2,675 | $2,432 | $2,860 | $567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 45 | 31 | 36 | 33 | 90 |
| TOTAL | $226 | $185 | $44 | $92 | $434 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31 | N/A | N/A | N/A | 45 |
| Deferred Revenues | 44 | N/A | 0 | 17 | 13 |
| Other Non-Current Liabilities | 43 | -108 | 0 | 238 | 178 |
| TOTAL | $120 | $0 | $0 | $0 | $45 |
| Total Liabilities | $346 | $185 | $44 | $92 | $479 |
| Shareholders' Equity | |||||
| Common Shares | 90 | 79 | 76 | 68 | 51 |
| Retained earnings | -27,802 | -23,868 | -19,769 | -13,170 | -11,301 |
| Other shareholders' equity | 0 | 0 | -14 | 0 | 0 |
| TOTAL | $2,525 | $2,383 | $2,388 | $3,006 | $266 |
| Total Liabilities And Equity | $2,871 | $2,568 | $2,432 | $3,099 | $745 |